{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T12:42:05Z","timestamp":1790080925902,"version":"4.0.1"},"reference-count":9,"publisher":"Hindawi Limited","issue":"1","license":[{"start":{"date-parts":[[2016,1,27]],"date-time":"2016-01-27T00:00:00Z","timestamp":1453852800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2016,1,27]],"date-time":"2016-01-27T00:00:00Z","timestamp":1453852800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Pharm Ther"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1111\/jcpt.12355","type":"journal-article","created":{"date-parts":[[2016,1,27]],"date-time":"2016-01-27T06:13:46Z","timestamp":1453875226000},"page":"104-105","source":"Crossref","is-referenced-by-count":30,"title":["Adverse event potentially due to an interaction between ibrutinib and verapamil: a case report"],"prefix":"10.1155","volume":"41","author":[{"given":"E.","family":"Lambert Kuhn","sequence":"first","affiliation":[{"name":"Pharmacy; Strasbourg University Hospital; Strasbourg France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Lev\u00eaque","sequence":"additional","affiliation":[{"name":"Pharmacy; Strasbourg University Hospital; Strasbourg France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Lioure","sequence":"additional","affiliation":[{"name":"Hematology\/Oncology Department; Strasbourg University Hospital; Strasbourg France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Gourieux","sequence":"additional","affiliation":[{"name":"Pharmacy; Strasbourg University Hospital; Strasbourg France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Bilbault","sequence":"additional","affiliation":[{"name":"Emergency Department; Strasbourg University Hospital; Strasbourg France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"98","published-online":{"date-parts":[[2016,1,27]]},"reference":[{"key":"10.1111\/jcpt.12355-BIB0001|jcpt12355-cit-0001","unstructured":"Imbruvica \u00ae summary of product characteristics October 2015 http:\/\/ec.europa.eu\/health\/documents\/community-register\/2015\/20150703132326\/anx_132326_fr.pdf"},{"key":"10.1111\/jcpt.12355-BIB0002|jcpt12355-cit-0002","doi-asserted-by":"crossref","first-page":"13075","DOI":"10.1073\/pnas.1004594107","article-title":"The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy","volume":"107","author":"Honigberg","year":"2010","journal-title":"Proc Natl Acad USA"},{"key":"10.1111\/jcpt.12355-BIB0003|jcpt12355-cit-0003","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1124\/dmd.114.060061","article-title":"Absorption, metabolism, and excretion of oral 14C radiolabeled ibrutinib: an open-label, phase I, single-dose study in healthy men","volume":"43","author":"Scheers","year":"2015","journal-title":"Drug Metab Dispos"},{"key":"10.1111\/jcpt.12355-BIB0004|jcpt12355-cit-0004","article-title":"Stable isotope-intravenous microdose for absolute bioavailability and effects of grapefruit juice on ibrutinib in healthy subjects","author":"Vries","year":"2015","journal-title":"Br J Clin Pharmacol"},{"key":"10.1111\/jcpt.12355-BIB0005|jcpt12355-cit-0005","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00280-014-2617-3","article-title":"Population pharmacokinetic model of ibrutinib, a Bruton tyrosine kinase inhibitor, in patients with B cell malignancies","volume":"75","author":"Marostica","year":"2015","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1111\/jcpt.12355-BIB0006|jcpt12355-cit-0006","doi-asserted-by":"crossref","first-page":"e00156","DOI":"10.1002\/prp2.156","article-title":"Effect of CYP3A perpetrators on ibrutinib exposure in healthy participants","volume":"3","author":"Jong","year":"2015","journal-title":"Pharmacol Res Perspect"},{"key":"10.1111\/jcpt.12355-BIB0007|jcpt12355-cit-0007","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.bulcan.2014.11.001","article-title":"Mecanisms of pharmacokinetic interactions involving oral anticancer agents (in French)","volume":"102","author":"Lev\u00eaque","year":"2015","journal-title":"Bull Cancer"},{"key":"10.1111\/jcpt.12355-BIB0008|jcpt12355-cit-0008","unstructured":"Alteis \u00ae summary of product characteristics October 2015 http:\/\/basedonnees-publique.medicaments.gouv.fr\/affichageDoc.php?specid=62597926&typedoc=R"},{"key":"10.1111\/jcpt.12355-BIB0009|jcpt12355-cit-0009","first-page":"1573","article-title":"New anticancer agents: role of clinical pharmacy services","volume":"34","author":"Lev\u00eaque","year":"2014","journal-title":"Anticancer Res"}],"container-title":["Journal of Clinical Pharmacy and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcpt.12355","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjcpt.12355","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jcpt.12355\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T18:06:09Z","timestamp":1671818769000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jcpt.12355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,27]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,2]]}},"URL":"https:\/\/doi.org\/10.1111\/jcpt.12355","archive":["Portico"],"relation":{},"ISSN":["0269-4727"],"issn-type":[{"value":"0269-4727","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1,27]]}}}